Elevated serum matrix metalloprotease (MMP-2) as a candidate biomarker for stable COPD.

Durga MahorVandana KumariKapil VashishtRuma GalgalekarRavindra M SamarthPradyumna K MishraNalok BanerjeeRajnikant DixitRohit SalujaSajal DeKailash C Pandey

Published in: BMC pulmonary medicine (2020)

The preliminary study of various serum proteases in stable COPD patients distinctly identified elevated MMP-2 as a candidate biomarker for COPD, subject to its validation in large cohort studies.

Keyphrases

chronic obstructive pulmonary disease
lung function
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
air pollution
patient reported outcomes